Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Genomics to be the Most Impactful Biopharmaceutical Market Trends | GlobalData Plc

Published

on

LONDON, June 08, 2022 (GLOBE NEWSWIRE) — As industries emerge from the impact of COVID-19, 2022 will be a year of readjustments and transition for many businesses worldwide. While the ongoing COVID-19 pandemic continues to restrain economic recovery, pharmaceutical companies will continue to leverage innovative technology to enable and accelerate business growth, enhance resilience, and remain competitive in this heavily disrupted business landscape.

The Biopharmaceutical Market Research Report offered by GlobalData Plc examines the business environment and trends that are going to shape the biopharmaceutical industry in 2022. Additionally, the report highlights the most impactful emerging technologies, industry, regulatory, and microeconomic factors that are going to impact and dominate the industry throughout 2022.

Key Findings

  • COVID-19-driven challenges and accelerated digitalization will continue to reshape the biopharmaceutical industry in 2022.
  • Genomics, immune-oncology (IO), and personalized medicine will dominate as the most impactful trends in the biopharmaceutical industry.
  • Drug pricing pressures will continue to hinder growth, forcing pharmaceutical companies to reassess their strategies and market focus
  • The pharmaceutical industry will be under increasing pressure to become more sustainable, with more companies committing to ESG strategies

For more key findings on the biopharmaceutical market, download a free report sample

Emerging Industry Trends in the Biopharmaceutical Market

  • Genomics
  • Immuno-oncology Drug Development
  • Personalized/Precision Medicine
  • Real-World Evidence
  • Remote Patient Monitoring
  • Electronic Health Records
  • Biosimilar Uptake
  • Decentralized/Virtual Clinical Trials
  • Digital Therapeutics
  • Patient Empowerment
  • Regenerative Medicine
  • Microbiome Drug Development
  • Nanomedicine
  • Medical Marijuana

The growth of the genomics market is being propelled by the increasing prevalence of chronic diseases, plummeting DNA sequencing costs, and growing funding for genomics. Genomics recently played a key role in the rapid development, approval, and rollout of the first COVID-19 vaccines, when advancing genomic sequencing allowed scientists to read the COVID- 19 genome almost immediately after the virus was identified.

For more insights on emerging industry trends in the biopharmaceutical market, download a free report sample

Emerging Regulatory and Macroeconomic Trends in the Biopharmaceutical Market

  • Drug Pricing & Reimbursement Constraints
  • Patent Expiry of Biologics
  • Environmental, Social, & Governance (ESG) Factors
  • Brexit
  • Political Divide in the US
  • China Impact
  • e-Pharmacies
  • Mega M&A
  • Vertical Integration of Healthcare Systems
  • Clinical Outsourcing
  • Manufacturing Outsourcing

Pricing is becoming a sustainability issue that ESG investors are increasingly mindful of. In the US, there are growing expectations that ICER guidance may in the future form a component of pharma companies’ evaluations against ESG targets, with investors potentially putting pressure on companies to align prices with ICER guidance.

For more insights on emerging regulatory and macroeconomic trends in the biopharmaceutical market, download a free report sample

Emerging Technologies in the Biopharmaceutical Market

  • Artificial Intelligence
  • Big Data
  • Social Media
  • Digital Media
  • Cybersecurity
  • Internet of Things
  • Robotics
  • Application Programming Interfaces (APIs)
  • Cloud Computing
  • 3D Printing
  • Virtual & Augmented Reality
  • Blockchain

AI and Big Data go hand in hand as the analysis of Big Data is best powered by AI. Competence in these areas is vital for healthcare companies, as it provides improved patient care at a micro-level and, more broadly, drives a higher level of insights and trends that benefit operational and clinical efficiency.

For more insights on emerging technologies in the biopharmaceutical market, download a free report sample

Biopharmaceutical Market Overview

Emerging Industry Trends Genomics, Immuno-Oncology Drug Development, Personalized/Precision Medicine, Real-World Evidence, Remote Patient Monitoring, Electronic Health Records, Biosimilar Uptake, Decentralized/Virtual Clinical Trials, Digital Therapeutics, Patient Empowerment, Regenerative Medicine, Microbiome Drug Development, Nanomedicine, and Medical Marijuana
Emerging Regulatory and Macroeconomic Trends Drug Pricing & Reimbursement Constraints, Patent Expiry of Biologics Environmental, Social, & Governance (ESG) Factors, Brexit, Political Divide in the US, China Impact, E-Pharmacies, Mega M&A, Vertical Integration of Healthcare Systems, Clinical Outsourcing, and Manufacturing Outsourcing
Emerging Technologies Artificial Intelligence, Big Data, Social Media, Digital Media, Cybersecurity, Internet of Things, Robotics, Application Programming Interfaces, Cloud Computing, 3D Printing, Virtual & Augmented Reality, and Blockchain

Biopharmaceutical Market Report Scope

The research source in this report is based on the opinions and expectations of 177 global healthcare industry professionals surveyed from November 17, 2021, to December 17, 2021, to gauge the 2022 outlook of the pharmaceutical industry. Respondents rated the anticipated impact of an emerging industry, regulatory, macroeconomic, and technology trends on the pharmaceutical industry during the upcoming 12 months.

Components of the report include:

  • Emerging Industry Trends – a snapshot of current attitudes of business leaders towards the emerging industry trends and how they are shaping the future of the healthcare industry
  • Emerging Regulatory and Macroeconomic Trends – overview of the hindrances and drivers that will affect the state of the biopharmaceutical industry
  • Emerging technologies – highlights emerging technologies that are expected to have the greatest impact on the biopharmaceutical industry in the next 12 months
  • Industry’s Growth Prospects – industry growth outlook: provides executives’ opinions on the growth prospects of the biopharmaceutical industry over the next 12 months
  • Watch Outs – key industry shake-ups and trends to watch that represent both challenges and opportunities to the industry

Reasons to Buy

  • Stay up to date with the major emerging technologies, and regulatory, macroeconomic, and industry trends that will impact the pharmaceutical industry in 2022.
  • Explore how the biopharmaceutical landscape has changed.
  • Identify the most impactful anticipated regulatory approvals and drug launches in the industry in 2022.
  • Gain insight into the regulatory and microeconomics trends that will have positive and negative effects on the biopharmaceutical industry.
  • Identify emerging industry trends and innovations to gain a competitive advantage.

FAQs

What are the emerging industry trends in the biopharmaceutical market?

The emerging industry trends of the biopharmaceutical market are genomics, immuno-oncology drug development, personalized/precision medicine, real-world evidence, remote patient monitoring, electronic health records, biosimilar uptake, decentralized/virtual clinical trials, digital therapeutics, patient empowerment, regenerative medicine, microbiome drug development, nanomedicine, and medical marijuana.

What are the emerging regulatory and macroeconomic trends in the biopharmaceutical market?

The emerging regulatory and macroeconomic trends in the biopharmaceutical market are drug pricing & reimbursement constraints, patent expiry of biologics environmental, social, & governance (ESG) factors, Brexit, the political divide in the US, China impact, e-pharmacies, mega M&A, vertical integration of healthcare systems, clinical outsourcing, and manufacturing outsourcing.

Which are the emerging technologies in the biopharmaceutical market?

The emerging technologies in the biopharmaceutical market are artificial intelligence, big data, social media, digital media, cybersecurity, the internet of things, robotics, application programming interfaces, cloud computing, 3D printing, virtual & augmented reality, and blockchain.

Related Reports

  • Chronic Kidney Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 – Click here
  • Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape – Click here
  • Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape – Click here
  • Colombia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape – Click here
  • Future of Pharma – Looking Ahead to 2022 – Click here

About us

GlobalData is a leading provider of data, analytics, and insights on the world’s largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData’s mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies.

Media Contacts

GlobalData

Mark Jephcott
Head of PR EMEA
[email protected]
cc: [email protected]

+44 (0)207 936 6400

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

IG Canada Announces Enhanced Trading Platform for Enhanced User Experience

Published

on

ig-canada-announces-enhanced-trading-platform-for-enhanced-user-experience

Meta description : Explore IG Canada’s advanced trading platform, educational resources, and robust security features. Achieve your trading goals with the innovative tools.
NOTTINGHAM, England, April 25, 2024 /PRNewswire/ — IG Canada, a premier online trading platform, is pleased to announce significant enhancements to its trading technology, designed to empower both novice and experienced traders with superior tools and resources. This development is part of IG Canada’s commitment to providing the best trading experience in the Canadian market.

IG Canada has upgraded its platform with advanced features that streamline trading processes and improve the accuracy of trade execution. These enhancements include customizable charts, a wider range of indicators, and improved mobile access, ensuring traders can operate efficiently from anywhere at any time.
Recognizing the importance of education in trading success, IG Canada has expanded its educational resources. The brokerage now offers a comprehensive learning center featuring webinars, tutorials, and articles that cater to various skill levels. These resources are designed to help traders develop robust trading strategies and improve their market knowledge.
Security remains a top priority for IG Canada. The latest updates include enhanced encryption and multi-factor authentication to protect client data and funds. These security measures provide peace of mind for traders, knowing their investments are safeguarded against potential threats.
IG Canada is a leading online brokerage that provides trading services across multiple asset classes, including forex, stocks, commodities, and indices. With a focus on innovation and customer service, IG Canada is committed to helping Canadian traders achieve their investment goals through a transparent and efficient trading environment.
In addition, IG Canada is committed to engaging with the community through upcoming webinars, live events, and partnerships with local financial experts. These initiatives are designed not only to support the growth and education of the clients but also to foster a stronger, more connected trading community in Canada.
Press Contact:Contact Name: Timothy C. SherwinEmail: [email protected] Phone: +447 441425053

View original content:https://www.prnewswire.co.uk/news-releases/ig-canada-announces-enhanced-trading-platform-for-enhanced-user-experience-302127189.html

Continue Reading

Artificial Intelligence

Sentrycs Now Part of the UK National Protective Security Authority Catalog of Security Equipment

Published

on

sentrycs-now-part-of-the-uk-national-protective-security-authority-catalog-of-security-equipment

This inclusion into the NPSA CSE marks a significant milestone in the company’s commitment to enhancing national and international airspace security and to leading the C-UAS market toward multi-layer strategy optimization and excellence.
TEL-AVIV, Israel, April 25, 2024 /PRNewswire/ — Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).
 
Following a rigorous assessment process, Sentrycs’ cutting-edge Counter Unmanned Aerial Systems (C-UAS) solution has met the high standards set by the NPSA for Detection, Tracking, and Identification (DTI). The testing, conducted at the NPSA’s designated testing facilities in August 2023, rigorously evaluated the Sentrycs system against the NPSA’s DTI Testing and Evaluation Standard v3.1.
Sentrycs elected to be assessed under Configuration D as a 3D system with Ground Control Station (GCS) detection capability and platform identification capability, which is the most demanding test scenario with the highest number of scored parameters.
The Sentrycs system demonstrated exceptional capabilities in various security scenarios, showcasing its robustness in detecting and tracking with high accuracy and zero false alarms. The system’s innovative use of cyber techniques to extract data from targets and its streamlined human-machine interface were especially noted for their efficiency and ease of use.
“Our team is proud to have Sentrycs recognized by the UK National Protective Security Authority,” said Yoav Zaltzman, CEO of Sentrycs. “Being listed in the CSE is not just an honor; it’s a testament to our technology’s reliability and effectiveness in contributing to the ever-changing airspace security landscape.”
Sentrycs’ technology is now accessible through the NPSA CSE, providing security practitioners with verified solutions that meet the UK’s rigorous security standards. This inclusion not only underscores Sentrycs’ role in advancing security technology but also enhances its visibility and credibility on a global stage.
For more details on Sentrycs’ solutions and their impact, visit www.sentrycs.com.
For further information regarding the NPSA and the Catalog of Security Equipment, please visit the NPSA’s official website.
About Sentrycs
Sentrycs is a leader in adaptive counter-drone solutions, supported by innovative technology designed to passively identify, mitigate, and where necessary, intercept unauthorized drones custom-built for various environments – including airports, borders, prisons, critical infrastructure, and mass events. Founded in 2017, Sentrycs’ has offices in Israel and the US, serving customers worldwide. By uniting its field-proven technology and expertise in global drone environments, Sentrycs is leading the way towards a safer and more secure drone-driven future. Learn more at www.sentrycs.com
Video – https://www.youtube.com/watch?v=YBuhpTq5QuM

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sentrycs-now-part-of-the-uk-national-protective-security-authority-catalog-of-security-equipment-302126952.html

Continue Reading

Artificial Intelligence

Homestyler to Recruit First Batch of Global Partners in 20 Countries

Published

on

homestyler-to-recruit-first-batch-of-global-partners-in-20-countries

MILAN, April 25, 2024 /PRNewswire/ — Homestyler, a leading all-in-one 3D Design platform and creative community for global designers invested by Easyhome New Retail Group and Alibaba Group, successfully hosted the Homestyler Global Partners Conference and Gorgeous Home Imported Brand Investment Promotion Conference from April 18 to 19 on the sidelines of the 2024 Salone del Mobile Milano, the world’s leading furniture fair.

Easyhome is at the forefront, driving the transformation of the home furnishing industry into a full-service platform. It has developed a tailored solution for global brands called Gorgeous Home, which includes supportive policies and has established local distribution and service networks in international markets. During the conference, Homestyler unveiled a suite of digital products enhanced by 3D and AI technologies, including cloud-based design tools, virtual livestreaming that can alter and restore furnishing scenes to true-to-life scale, a 3D Floor Planner, a 3D Virtual Studio, and a 3D Interactive Panorama, among others. The event also marked the signing ceremony with the first group of global partners.
The Global Partners Program is a key milestone of Homestyler’s roadmap towards global commercialization. It has established close partnerships with around 1,000 global home furnishing companies and design institutions to provide solutions for digital transformation. The first global partners from more than 20 countries and regions will collaborate to explore content creation and marketing potential to deliver effective growth.
In addition, Homestyler shared the unique advantages of its software and cloud designing tools, particularly in cloud rendering, free modeling capabilities, 3D model and material libraries, one-stop workflow, and user-friendliness.
“The core technologies and products of Homestyler extend through all links both online and offline and deeply converge physical experience with digital technologies, such as attracting customers, content design and creation, interactive scene, check-out tracking and more, and we continue to optimize and enhance the 3D scenario shopping experience to empower the transformation and upgrading of the global home furnishing industry,” said Ma Xingjian, head of Homestyler’s overseas business.
Looking ahead, Easyhome and Homestyler aims to establish an international service, regional distribution and dealership system, serving as a bridge between global designers and home furnishing companies worldwide to enable designers residing in different countries and regions to highlight their 3D design solutions and boost shopping experience for the consumers.
As a creative hub for global designers, Homestyler continually expands its model library with home furnishing products from around the world and provides the latest in 3D and AI technologies to help companies promote their products across various channels. Companies such as P Life Concept London, Lahoma Ltd., and Tecnobit S.r.l. are leveraging Homestyler products to enhance the online shopping experience and increase efficiency on their websites. Homestyler plans to introduce more B2B digital products and services, including advanced 3D tools for designing, modeling, rendering, virtual studio shooting, and livestreaming. “Homestyler will further advance our international development: we are planning to establish industry-academy cooperation with Italy’s top design institution, the Polytechnic University of Milan, and the relationship with ADI. With the launch of Global Partners Program, Homestyler will continue to invest in supporting policies and boost international influence through various cooperation programs, to achieve the goal of providing better design services for users globally,” said Xu Min, general manager of Homestyler.
For more information, please visit https://www.homestyler.com.
About Homestyler
Homestyler was jointly invested in by Easyhome New Retail Group and Alibaba Group. It is dedicated to provide 3D cloud design tools for designers worldwide and delivering a comprehensive suite of 3D+AI digital solutions to the furniture and home furnishing industry.

View original content:https://www.prnewswire.co.uk/news-releases/homestyler-to-recruit-first-batch-of-global-partners-in-20-countries-302127111.html

Continue Reading

Trending